BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 3922124)

  • 21. Evaluation of sodium etidronate in the treatment of Paget's disease of bone. Osteitis deformans.
    Stein I; Shapiro B; Ostrum B; Beller ML
    Clin Orthop Relat Res; 1977; (122):347-58. PubMed ID: 402246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of Paget's disease with the combined administration of calcitonin and disodium etidronate].
    Ghiringhelli G; Fogel M; Varela de Rodríguez J; Casco C; Mautelén C; Nusimovich B
    Medicina (B Aires); 1982; 42(1):16-20. PubMed ID: 6813634
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of Paget's disease of bone: diphosphonates or calcitonin?].
    Davoine GA; Jung A; Courvoisier B
    Schweiz Med Wochenschr; 1981 Apr; 111(15):518-24. PubMed ID: 6785879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pseudosarcomatous osteolysis in a Paget's disease patient treated with disodium etidronate (EHDP)].
    Rondier J; Huchet B; Cayla J
    Rev Rhum Mal Osteoartic; 1984 Jan; 51(1):49-54. PubMed ID: 6420876
    [No Abstract]   [Full Text] [Related]  

  • 25. Effective oral treatment of severe Paget's disease of bone with APD (3-amino-1-hydroxypropylidene-1,1-bisphosphonate); a comparison with combined calcitonin + EHDP (1-hydroxyethylidene-1,1-bisphosphonate).
    Fraser TR; Ibbertson HK; Holdaway IM; Rutland M; King A; Dodd G; Wattie DJ
    Aust N Z J Med; 1984 Dec; 14(6):811-8. PubMed ID: 6442563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation of skeletal uptake of 99mTc-diphosphonate and alkaline phosphatase before and after oral diphosphonate therapy in Paget's disease.
    Smith ML; Fogelman I; Ralston S; Boyce BF; Boyle IT
    Metab Bone Dis Relat Res; 1984; 5(4):167-70. PubMed ID: 6429474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term follow-up of therapy with intermittent etidronate disodium in Paget's disease of bone.
    Altman RD
    Am J Med; 1985 Nov; 79(5):583-90. PubMed ID: 3933343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An apparent 1,25-dihydroxyvitamin D-independent stimulation of intestinal calcium absorption in patients with Paget disease of bone during a short-term diphosphonate therapy.
    Norman DA; Zerwekh JE; Pak CY
    Metabolism; 1981 Mar; 30(3):290-2. PubMed ID: 6782425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A patient with Paget's disease of bone treated with etidronate disodium.
    Koga K; Kawasaki K; Kohno S; Yamada K; Itoh T; Nonaka K
    Kurume Med J; 1998; 45(4):345-9. PubMed ID: 9914722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of 1 alpha-hydroxyvitamin D3 on the mineralization defect in disodium etidronate-treated Paget's disease--a double-blind randomized clinical study.
    Ralston SH; Boyce BF; Cowan RA; Fogelman I; Smith ML; Jenkins A; Boyle IT
    J Bone Miner Res; 1987 Feb; 2(1):5-12. PubMed ID: 3137773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of Paget's disease with phosphonates].
    Reiner M; Jung A; Seiler A; Schenk R; Fleisch H
    Schweiz Med Wochenschr; 1975 Dec; 105(50):1701-3. PubMed ID: 1215960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of Paget's disease of bone.
    Evans RA
    Med J Aust; 1983 Feb; 1(4):159-62. PubMed ID: 6405139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Procollagen-III peptide serum levels in Paget's disease of the bone.
    Wilder-Smith CH; Raue F; Holz-Gottswinter G; Ziegler R
    Klin Wochenschr; 1987 Feb; 65(4):174-8. PubMed ID: 3104661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative study of alendronate versus etidronate for the treatment of Paget's disease of bone.
    Siris E; Weinstein RS; Altman R; Conte JM; Favus M; Lombardi A; Lyles K; McIlwain H; Murphy WA; Reda C; Rude R; Seton M; Tiegs R; Thompson D; Tucci JR; Yates AJ; Zimering M
    J Clin Endocrinol Metab; 1996 Mar; 81(3):961-7. PubMed ID: 8772558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Amino-hydroxy-propylidene biphosphonate in the treatment of Paget's disease resistant to calcitonin and/or etidronate].
    Miravet L; Kuntz D
    Rev Rhum Mal Osteoartic; 1989 Mar; 56(4):287-92. PubMed ID: 2496460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diphosphonate treatment of Paget's disease.
    Finerman GA; Gonick HC; Smith RK; Mayfield JM
    Clin Orthop Relat Res; 1976 Oct; (120):115-24. PubMed ID: 975646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spontaneous fractures of uninvolved bones in patients with Paget's disease during unduly prolonged treatment with disodium etidronate (EHDP).
    Mautalen C; Gonzalez D; Blumenfeld EL; Santini Araujo E; Schajowicz F
    Clin Orthop Relat Res; 1986 Jun; (207):150-5. PubMed ID: 3087670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined diphosphonate and calcitonin therapy for Paget's disease of bone.
    Hosking DJ; Bijvoet OL
    Calcif Tissue Res; 1976 Aug; 21 Suppl():321-6. PubMed ID: 821599
    [No Abstract]   [Full Text] [Related]  

  • 39. Paget's bone disease treated with diphosphonate and calcitonin.
    Hosking DJ; Bijvoet OL; van Aken J; Will EJ
    Lancet; 1976 Mar; 1(7960):615-7. PubMed ID: 55896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effective short term treatment of Paget's disease with oral etidronate.
    Preston CJ; Yates AJ; Beneton MN; Russell RG; Gray RE; Smith R; Kanis JA
    Br Med J (Clin Res Ed); 1986 Jan; 292(6513):79-80. PubMed ID: 3080099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.